Table 1

Incidence of HIE for the whole study population, infants ≥36 weeks gestational age with moderate/severe HIE and infants ≥36 weeks gestational age with moderate/severe HIE treated with TH

YearAny HIEModerate/severe HIE and ≥36 gestational weeks at birth
nRate per
1000 live births
nRate per
1000 live births
Received TH
(n)
Received TH
(%)
Received or
died without TH
(n)
Received or
died without TH
(%)
2011*2253
(2320–2372)
3.22
(3.32–3.39)
1592
(1631–1668)
2.33
(2.33–2.39)
694
(704–706)
43.6
(42.3–43.2)
722
(733–735)
45.4
(43.9–45.1)
201219162.7112671.8372357.174158.5
201319062.8112131.8380666.482367.8
201421353.1714222.1693765.995166.9
201521043.1113962.1192866.595368.3
201618812.7712761.9386167.587968.9
Total12 1952.9681662.03494960.6506962.1
Epoch 1*6075
(6142–6194)
2.91
(2.94–2.96)
4072
(4111–4138)
2.00
(2.01–2.03)
2223
(2233–2235)
54.6†
(54.0–54.4†)
2286
(2297–2299)
56.1†
(55.5–55.9†)
Epoch 261203.0140942.07272666.6†278368.0†
  • *Range included to account for 2011 data not available for all hospitals (see the Methods section).

  • †Significant change between epoch 1 and epoch 2 (p<0.001).

  • HIE, hypoxic-ischaemic encephalopathy; TH, therapeutic hypothermia.